Abaloparatide

Status:
Do Not Prescribe (DNP)
Decision Date:
June 2023
 

Comments

DNP: Treatment of osteoporosis in postmenopausal women at increased risk of fracture. Awaiting national guidance. 

ICB commissioned 

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app